Results 181 to 190 of about 20,887 (223)

Circulating Beta3-Adrenoreceptor as Novel Independent Biomarker for Risk Assessment in Neuroblastoma Patients. [PDF]

FASEB J
Favre C, Mattei G, Banella C, Pasha A, Crucitta S, Bruno G, Amato R, Rosa C, Pini A, Nardini P, Lunardi F, Carra F, Trevisan F, De Marco E, Tellini M, Trambusti I, Micheletti MV, Pasqualetti F, Casazza G, Tondo A, Calvani M.   +20 more
europepmc   +1 more source

Alternative Splicing of the NF-Y Subunit, NF-YA, in Neuroblastoma Phenotype Heterogeneity. [PDF]

Cancers (Basel)
Martelli I, Cappabianca LA, Sbaffone M, Farina AR, Mackay AR.   +4 more
europepmc   +1 more source

A taurine metabolism-related gene program defines clinical and biological features of neuroblastoma and yields an 8-gene candidate prognostic model. [PDF]

Transl Pediatr
Zhong B, Zhang Y, Wang Z, Dong Q, Li X, Xia Y.   +5 more
europepmc   +1 more source

The MYCN Protein in Health and Disease [PDF]

Genes, 2017
MYCN is a member of the MYC family of proto-oncogenes. It encodes a transcription factor, MYCN, involved in the control of fundamental processes during embryonal development. The MYCN protein is situated downstream of several signaling pathways promoting cell growth, proliferation and metabolism of progenitor cells in different developing organs and ...
Marie Arsenian Henriksson, Áine Brigette Henley   +1 more
exaly   +4 more sources

Some of the next articles are maybe not open access.

Related searches:

MYCN gain and MYCN amplification in a stage 4S neuroblastoma

Cancer Genetics and Cytogenetics, 2003
Stage 4S neuroblastoma is a disease associated with spontaneous regression and good survival. We present a patient whose evolution has shown the variety and complexity of this disease in infants. Biologic factors, such as ploidy, MYCN copy number, loss of 1p36, and other chromosomal gains and losses were determined.
Rosa, Noguera, Adela, Cañete, Antonio, Pellín, Amparo, Ruiz, María, Tasso, Samuel, Navarro, Victoria, Castel, Antonio, Llombart-Bosch   +7 more
openaire   +2 more sources

MYCN in neuronal tumours

Cancer Letters, 2004
MYCN is a member of the MYC family of oncogenes that encode nuclear proteins serving as transcription factors. Activation of MYC family genes, usually by genetic damage with the consequence of enhanced expression of a wild-type protein, has been found to participate in human and animal cancers.
openaire   +2 more sources

MYCN and MicroRNAs

2015
MicroRNAs (miRNAs) are small noncoding RNAs that downregulate translation of mRNAs into proteins by specifically binding the 3′-untranslated regions (UTRs).
Althoff, Kristina, Schulte, Johannes
openaire   +1 more source

MYCN Amplification by Differential PCR

Pediatric Hematology and Oncology, 1993
A method is described to estimate MYCN (N-myc) oncogene amplification in neuroblastoma by the technique of differential polymerase chain reaction (PCR). The technique is quicker than conventional Southern blotting techniques and does not require radioactive materials.
S N, Huddart, J R, Mann, A G, McGukin, R, Corbett   +3 more
openaire   +2 more sources

MYCN immunohistochemistry as surrogate marker for MYCN-amplified spinal ependymomas

Human Cell
MYCN (master regulator of cell cycle entry and proliferative metabolism) gene amplification defines a molecular subgroup of spinal cord ependymomas that show high-grade morphology and aggressive behavior. Demonstration of MYCN amplification by DNA methylation or fluorescence-in situ hybridization (FISH) is required for diagnosis. We aimed to (i) assess
Divya, Mohan, Aruna, Nambirajan, Rafat, Malik, Agrima, Sharma, Vaishali, Suri, Kavneet, Kaur, Ramesh, Doddamani, Ajay, Garg, Subhash, Gupta, Supriya, Mallick, Mehar Chand, Sharma   +10 more
openaire   +2 more sources